Drugmakers divided over Poland’s new pharma litigation rules
A new civil code amendment grants IP judges more discretion, leaving generic and innovative drug makers divided on its merits
drug innovation
Czechia’s generic-heavy pharma sector downplays US tariff risks
The Czech generic industry and the trade ministry remain untroubled by US tariffs, but innovative drug companies are anxious
Sweden backs EU-wide patent reform to support drug innovation
The question of how changes to the unitary system will affect medicine prices remains, with civil society warning of further hurdles to access.
Czechs can’t get no, innovation… patients enduring long delays for new meds
Thousands of Czech patients remain without access to urgent innovative medicines, despite recent progress.
‘Change course on EU Medicines Act revisions’ Dutch pharma association urges government
Staying the course would mean the Netherlands would lose out on around €70 million in R&D investments each year, said pharma association, VIG.
Ireland sees Budget 2025 funding boost for new medicines [Advocacy Lab Content]
Expected funding for new medicines in Ireland’s ‘Budget 2025’ has been welcomed by members of the Irish pharmaceutical industry, which predicts the sector will make reimbursement applications for 36 medicines in 2025, benefitting as many as 3,700 patie…
Sanofi calls for next Commission to boost Europe’s research capabilities [Advocacy Lab Content]
Sanofi is emphasising the strategic importance of Belgium in its pharmaceutical research and development initiatives, while also highlighting the EU’s potential to lead an artificial intelligence-driven revolution in medicine, particularly in medicines…
Belgium developing new class of antibiotics, but incentives and market support needed [Advocacy Lab Content]
The pipeline of new antibiotics to curb the antimicrobial resistance crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives.
Irish pharma sector quizzes European election candidates on innovation, sustainability, and regulation [Advocacy Lab Content]
Irish candidates for the upcoming European parliament elections are attending a series of health manifesto events where pharmaceutical industry experts, the press and the public are quizzing candidates’ support for innovation and sustainability.
Former Dutch vaccines envoy says EU pharma framework should focus on innovation
Accelerating access to innovation for patients, and providing predictability in the high-risk environment of drug making is critical, a former Dutch vaccines envoy has told Euractiv, adding that the current EU pharmaceutical framework is unsustainable …